Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

1.2K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.2K
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

1.1K
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
1.1K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

250
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
250
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

512
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
512
Lipid Catabolism01:25

Lipid Catabolism

649
Triglycerides serve as crucial long-term energy storage molecules in microorganisms, providing a dense source of metabolic energy. Their breakdown is mediated by lipases, which hydrolyze triglycerides into glycerol and free fatty acids. Each of these components follows distinct metabolic pathways, ultimately contributing to ATP synthesis and cellular energy homeostasis.Glycerol MetabolismGlycerol, released from triglyceride hydrolysis, is phosphorylated by glycerol kinase to form...
649
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

161
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
161

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Modern treatment of type 2 diabetes: 3 medications and 3 targets].

Praxis·2026
Same author

[A Somehow Different Cause of an Upper Gastrointestinal Bleeding].

Praxis·2024
Same author

Recommendations for early identification of heart failure in patients with diabetes: Consensus statement of the Swiss Society of Endocrinology and Diabetology and the Heart Failure Working Group of the Swiss Society of Cardiology.

Swiss medical weekly·2024
Same author

[Type 2 diabetes and pregnancy: management from preconception to the postpartum].

Revue medicale suisse·2024
Same author

[Towards a new way to classify diabetes mellitus].

Revue medicale suisse·2024
Same author

Metabolic and inflammatory parameters in relation to baseline characterization and treatment outcome in patients with prolactinoma: insights from a retrospective cohort study at a single tertiary center.

Frontiers in endocrinology·2024

Related Experiment Video

Updated: Dec 13, 2025

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes
10:56

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes

Published on: September 15, 2018

8.4K

[CME: Primary and Secondary Hypercholesterolemia].

Susanna Hofbauer1, Peter Wiesli1

  • 1Endokrinologie/Diabetologie, Kantonsspital Frauenfeld.

Praxis
|August 6, 2020
PubMed
Summary
This summary is machine-generated.

Familial hypercholesterolemia, a genetic condition causing high LDL-cholesterol, requires medical therapy and family screening. Secondary causes of high cholesterol, like hypothyroidism, must also be ruled out before treatment.

Keywords:
HypercholesterinämieHypercholesterolemiaHypothyreosechronic autoimmune thyroiditschronische Autoimmunthyreoiditishypothyreosis

More Related Videos

Cholesterol Efflux Assay
07:54

Cholesterol Efflux Assay

Published on: March 6, 2012

30.5K
LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring
08:45

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring

Published on: November 17, 2018

13.9K

Related Experiment Videos

Last Updated: Dec 13, 2025

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes
10:56

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes

Published on: September 15, 2018

8.4K
Cholesterol Efflux Assay
07:54

Cholesterol Efflux Assay

Published on: March 6, 2012

30.5K
LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring
08:45

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring

Published on: November 17, 2018

13.9K

Area of Science:

  • Cardiology
  • Genetics
  • Metabolic Disorders

Background:

  • Hypercholesterolemia, characterized by elevated LDL-cholesterol, necessitates distinguishing between primary (genetic) and secondary (acquired) causes.
  • Familial hypercholesterolemia (FH) is a prevalent genetic disorder leading to significantly high cholesterol levels from birth.

Purpose of the Study:

  • To outline diagnostic considerations for primary hypercholesterolemia (familial hypercholesterolemia) in patients with elevated LDL-cholesterol.
  • To emphasize the importance of identifying secondary causes of hypercholesterolemia before initiating lipid-lowering therapy.

Main Methods:

  • Clinical diagnosis supported by family history and specific diagnostic findings.
  • Utilizing the Lipid Clinic Network Score to estimate the likelihood of familial hypercholesterolemia.
  • Evaluating exogenous factors and medical conditions that can lead to secondary hypercholesterolemia.

Main Results:

  • Patients with LDL-cholesterol >5 mmol/l should be evaluated for familial hypercholesterolemia.
  • Diagnosis of FH is supported by clinical findings, family history, and potentially the Lipid Clinic Network Score.
  • Secondary hypercholesterolemia can result from hypothyroidism, cholestasis, nephrotic syndrome, or certain medications.

Conclusions:

  • Prompt identification and management of familial hypercholesterolemia are crucial due to its genetic basis and associated cardiovascular risks.
  • Screening relatives of FH patients is essential for early detection and intervention.
  • Excluding secondary causes of hypercholesterolemia is a critical step prior to suspecting FH or commencing lipid-lowering treatments.